Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of an investigational blood/body fluid agent versus epoetin in Japan
jRCT2080222384Phase 2Completed
- Start
- Feb 2014
- Modality
- Recombinant Proteins and Enzymes
01
Overview
Phase 2 trial of Epoetin alfa RB (2 arms). Started Feb 2014; status: completed.
02
Drugs
Epoetin alfa RB
Beyond the preview
Go deeper on jRCT2080222384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222384.